DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

Johnson & Johnson (NYSE: JNJ)



company name or ticker
Company Photos
(Click to zoom)

The Zacks Analyst Blog Highlights: Caterpillar, McDonald's, 3M, Procter & Gamble and Johnson & Johns

The Zacks Analyst Blog Highlights: Caterpillar, McDonald's, 3M, Procter & Gamble and Johnson & Johnson

These Drugs Are Actually Moving The Needle For Johnson & Johnson

Sales for its hepatitis C drug are falling off a cliff, but revenue from these fast-growing therapies more than make up for it.

Why TransEnterix, Inc. Shares Are Soaring Today

Rumors of a potential acquisition continue to cause shares to pop and drop.

PLx Pharma IPO: Consider Holding Off

The Single Best Stock to Own Today

Don't settle for anything less than having this company in your portfolio.

Warm Up With This Low Volatility ETF

Reducing Volatility While Staying In The Stock Market With USMV

Johnson & Johnson Wants Investors to Ignore Falling Hepatitis C Drug Sales

Olysio's flash-in-the-pan success may be unfairly and negatively skewing investors' perception of Johnson & Johnson's performance.

J&J (JNJ) Beats on 4Q Earnings but Misses on Revenues

JOHNSON & JOHNSON (JNJ) Earnings Report: Q4 2015 Conference Call Transcript

See More Articles...